Here are four recent news updates on key gastroenterology and endoscopy companies.
Olympus introduced the FDA-cleared EZ Shot 3 Plus single use aspiration needle.
EndoChoice stock declined 6.36 percent in short interest.
The European Commission approved the Swiss-based Novartis drug Afinitor for advanced gastrointestinal and lung neuroendocrine tumor treatment.
SpectraScience completed training for the first group of physicians using the WavSTAT4 Optical Biopsy SystemR in Barcelona, Spain.